BioAge Labs (BIOA) Research & Development (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Research & Development data on file, last reported at $20.4 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 83.72% year-over-year to $20.4 million; the trailing twelve-month figure through Mar 2026 stood at $83.3 million (up 36.9% YoY), and the FY2025 full-year result was $74.0 million, up 25.29% from the prior year.
• Research & Development fell to $20.4 million in Q1 2026, from $24.5 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $24.5 million in Q4 2025 to a low of $6.5 million in Q3 2023.
• A 4-year average of $15.5 million and a median of $18.5 million in 2025 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 206.48% in 2024 and slipped 7.52% in 2025, its largest moves.
• Tracing BIOA's Research & Development over 4 years: stood at $10.1 million in 2023, then soared by 90.69% to $19.2 million in 2024, then climbed by 27.44% to $24.5 million in 2025, then decreased by 16.69% to $20.4 million in 2026.
• Business Quant data shows BIOA's Research & Development at $20.4 million in Q1 2026, $24.5 million in Q4 2025, and $18.5 million in Q3 2025.